caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1437224524

Lei ZhengMD

Medical OncologySan Antonio, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Lei Zheng's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 10 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Elliot Fishman
Diagnostic Radiology · Baltimore, MD
73238
BIEDRZYCKI, BARBARA22144
Johns Hopkins University
Clinical Laboratory · Baltimore, MD
1837
Siva Raman
Diagnostic Radiology · Walnut Creek, CA
1758
HERMAN, JOSEPH1598
Salina Tsai
Diagnostic Radiology · Dallas, TX
1258
Satomi Kawamoto
Diagnostic Radiology · Baltimore, MD
1237
KAMEL, IHAB1230
David Feigin
Diagnostic Radiology · Baltimore, MD
1128
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
THE JOHNS HOPKINS HOSPITAL118874
HORTON, KAREN2691
BLEICH, KAREN24114
Elliot Fishman
Diagnostic Radiology · Baltimore, MD
2150
HERMAN, JOSEPH17150
BIEDRZYCKI, BARBARA17103
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1494
KELLY, RONAN1336
David Feigin
Diagnostic Radiology · Baltimore, MD
1347
Linda Chu
Diagnostic Radiology · Baltimore, MD
1139
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
24
Beneficiaries
—
Total drug cost
$107K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Lipase/Protease/Amylase13 claims
Lipase/Protease/Amylase11 claims
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$264
Payment records
6
By payment type
Food and Beverage$264
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
174
Unique beneficiaries
—
Total services
219
Distinct HCPCS
3
Medicare payment
$18K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — bottom quintile (cohort median 4,999).